Figure 2From: Dispersion of hyperenhancement in late gadolinium enhancement cardiovascular magnetic resonance measured with Moran's I is associated with a decrement in LVEF 6 months after cardiotoxic chemotherapyLongitudinal measurements of left ventricular ejection fraction (LVEF, Panel A), late gadolinium enhancement signal intensity (LGE-SI, Panel B), and LGE-SI pattern (Moran's I, Panel C) measured with 1.5T cardiovascular magnetic resonance prior to chemotherapy administration (month 0) and again 3 and 6 months after administration of cardiotoxic chemotherapy. Mean values ± standard deviation shown in each panel. Significant differences from baseline by paired t-tests with p-values<0.05 indicated by (*); p-value listed in each panel is for analysis of trend using one-way ANOVA.Back to article page